Mechanistic studies uncovered that SOX17 promoted transcription and release of miR‐224‐5p and miR‐361‐3p, thereby targeting NR4A3 and PCSK9 to improve endothelial dysfunction (Figure7). The gene discussed is NR4A3; the disease is endothelial dysfunction.